(Q44791824)

6 December 2017

title

Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy (English)

1 reference

positron emission tomography

6 December 2017

0 references

1 reference

Mathias K Fehr

1

1 reference

6 December 2017

Rene Hornung

2

1 reference

6 December 2017

Zsuzsanna Varga

3

1 reference

6 December 2017

Daniel Burger

4

1 reference

6 December 2017

Thomas Hess

5

1 reference

6 December 2017

Urs Haller

6

1 reference

6 December 2017

Daniel Fink

7

1 reference

6 December 2017

Gustav K von Schulthess

8

1 reference

6 December 2017

Hans C Steinert

9

1 reference

6 December 2017

publication date

1 March 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

10

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

89-93

1 reference

describes a project that uses

6 December 2017

positron emission tomography

1 reference

Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center.

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Sentinel lymphatic mapping in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Selective axillary surgery in breast cancer patients based on positron emission tomography with 18F-fluoro-2-deoxy-D-glucose: not yet!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Determinants of diagnostic performance of [F-18]fluorodeoxyglucose positron emission tomography for axillary staging in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

The sentinel node in breast cancer--a multicenter validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Sentinel node biopsy in breast cancer: recommendations for surgeons, pathologists, nuclear physicians and radiologists in Australia and New Zealand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

Association between [ 18 F]fluorodeoxyglucose uptake and postoperative histopathology, hormone receptor status, thymidine labelling index and p53 in primary breast cancer: a preliminary observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21455.X

10.1111/J.1075-122X.2004.21455.X

21 January 2018

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jwxjm73b3vbyrezyzp6l2hl5be

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_jwxjm73b3vbyrezyzp6l2hl5be

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jwxjm73b3vbyrezyzp6l2hl5be

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/jwxjm73b3vbyrezyzp6l2hl5be

1 reference

30 July 2022